Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Diabetes

nab-P/C demonstrated improved efficacy and manageable tolerability in patients with advanced NSCLC and diabetes.